Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Damora Therapeutics, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Damora Therapeutics, Inc.Listing unverified | Exercise | — | SEC | |
Damora Therapeutics, Inc.Listing unverified | Exercise | — | SEC | |
Damora Therapeutics, Inc.Listing unverified | ExerciseD (derivative) | — | SEC | |
Damora Therapeutics, Inc.Listing unverified | ExerciseD (derivative) | — | SEC | |
Jade Biosciences, Inc.Listing unverified | Award | $12.2M | SEC | |
Jade Biosciences, Inc.Listing unverified | AwardD (derivative) | $7.8M | SEC | |
Zenas BioPharma, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Spyre Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Spyre Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Viridian Therapeutics, Inc.\DEListing on record | Buy | $30M | SEC | |
Viridian Therapeutics, Inc.\DEListing on record | Other | — | SEC | |
Viridian Therapeutics, Inc.\DEListing on record | OtherD (derivative) | — | SEC | |
Viridian Therapeutics, Inc.\DEListing on record | Other | — | SEC | |
Viridian Therapeutics, Inc.\DEListing on record | OtherD (derivative) | — | SEC | |
Viridian Therapeutics, Inc.\DEListing on record | Buy | $10M | SEC | |
Spyre Therapeutics, Inc.Listing on record | Other | — | SEC | |
Spyre Therapeutics, Inc.Listing on record | Other | — | SEC | |
Spyre Therapeutics, Inc.Listing on record | Other | — | SEC | |
MedGen, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
MedGen, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
MedGen, Inc.Listing unverified | Other | — | SEC | |
MedGen, Inc.Listing unverified | Other | — | SEC |